Go to
JCI Insight
Citations to this article
William R. Morgenlander, … , Aaron A.R. Tobian, H. Benjamin Larman
Published February 11, 2021
Citation Information: J Clin Invest. 2021;131(7):e146927. https://doi.org/10.1172/JCI146927.
Citation Information: J Clin Invest. 2021;131(7):e146927. https://doi.org/10.1172/JCI146927.
Abstract
SARS-CoV-2 (CoV2) antibody therapies, including COVID-19 convalescent plasma (CCP), monoclonal antibodies, and hyperimmune globulin, are among the leading treatments for individuals with early COVID-19 infection. The functionality of convalescent plasma varies greatly, but the association of antibody epitope specificities with plasma functionality remains uncharacterized. We assessed antibody functionality and reactivities to peptides across the CoV2 and the 4 endemic human coronavirus (HCoV) genomes in 126 CCP donations. We found strong correlation between plasma functionality and polyclonal antibody targeting of CoV2 spike protein peptides. Antibody reactivity to many HCoV spike peptides also displayed strong correlation with plasma functionality, including pan-coronavirus cross-reactive epitopes located in a conserved region of the fusion peptide. After accounting for antibody cross-reactivity, we identified an association between greater alphacoronavirus NL63 antibody responses and development of highly neutralizing antibodies against CoV2. We also found that plasma preferentially reactive to the CoV2 spike receptor binding domain (RBD), versus the betacoronavirus HKU1 RBD, had higher neutralizing titer. Finally, we developed a 2-peptide serosignature that identifies plasma donations with high anti-spike titer, but that suffer from low neutralizing activity. These results suggest that analysis of coronavirus antibody fine specificities may be useful for selecting desired therapeutics and understanding the complex immune responses elicited by CoV2 infection.
Authors
William R. Morgenlander, Stephanie N. Henson, Daniel R. Monaco, Athena Chen, Kirsten Littlefield, Evan M. Bloch, Eric Fujimura, Ingo Ruczinski, Andrew R. Crowley, Harini Natarajan, Savannah E. Butler, Joshua A. Weiner, Mamie Z. Li, Tania S. Bonny, Sarah E. Benner, Ashwin Balagopal, David Sullivan, Shmuel Shoham, Thomas C. Quinn, Susan H. Eshleman, Arturo Casadevall, Andrew D. Redd, Oliver Laeyendecker, Margaret E. Ackerman, Andrew Pekosz, Stephen J. Elledge, Matthew Robinson, Aaron A.R. Tobian, H. Benjamin Larman
Citation information
Citations to this article (62)
| Title and authors | Publication | Year |
|---|---|---|
|
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Naiditch H, Betts MR, Larman HB, Levi M, Rosenberg AZ |
Frontiers in Immunology | 2025 |
|
SARS-CoV-2 IgG Antibodies in COVID-19 Convalescent Plasma and Conventional Plasma Units
Sulaiman A, Sengsouk I, White JL, Marshall C, Fernandez RE, Redd AD, Eby Y, Casadevall A, Sullivan D, Gebo K, Shoham S, Laeyendecker O, Rai H, Bloch EM, Crowe EP, Tobian AA |
Transfusion | 2025 |
|
Circulating Antibodies Against Common Cold Coronaviruses Do Not Interfere with Immune Responses to Primary or Booster SARS-CoV-2 mRNA Vaccines
Adhikari B, Oltz EM, Gumina RJ, Kick MK, Saif LJ, Vlasova AN |
Vaccines | 2025 |
|
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
Collins CP, Longo DL, Murphy WJ |
Frontiers in immunology | 2024 |
|
Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
Karaba AH, Morgenlander WR, Johnston TS, Hage C, Pekosz A, Durand CM, Segev DL, Robien MA, Heeger PS, Larsen CP, Blankson JN, Werbel WA, Larman HB, Tobian AAR |
The Journal of Infectious Diseases | 2024 |
|
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals
Adami FL, de Castro MV, Almeida BD, Daher IP, Yamamoto MM, Souza Santos K, Zatz M, Naslavsky MS, Rosa DS, Cunha-Neto E, de Oliveira VL, Kalil J, Boscardin SB |
Frontiers in immunology | 2024 |
|
Precision arbovirus serology with a pan-arbovirus peptidome
Morgenlander WR, Chia WN, Parra B, Monaco DR, Ragan I, Pardo CA, Bowen R, Zhong D, Norris DE, Ruczinski I, Durbin A, Wang LF, Larman HB, Robinson ML |
Nature Communications | 2024 |
|
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Guenthoer J, Garrett ME, Lilly M, Depierreux DM, Ruiz F, Chi M, Stoddard CI, Chohan V, Yaffe ZA, Sung K, Ralph D, Chu HY, Matsen FA IV, Overbaugh J |
PLoS pathogens | 2024 |
|
PhIP-Seq: methods, applications and challenges
Huang Z, Gunarathne SM, Liu W, Zhou Y, Jiang Y, Li S, Huang J |
Frontiers in Bioinformatics | 2024 |
|
High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines
Joseph JO, Ylade M, Daag JV, Aogo R, Crisostomo MV, Mpingabo P, Premkumar L, Deen J, Katzelnick LC |
BMC Infectious Diseases | 2024 |
|
Phage Immunoprecipitation and Sequencing—a Versatile Technique for Mapping the Antibody Reactome
Sundell GN, Tao SC |
Molecular & Cellular Proteomics : MCP | 2024 |
|
Comprehensive phage display viral antibody profiling using VirScan: potential applications in chronic immune-mediated disease.
Shrewsbury JV, Vitus ES, Koziol AL, Nenarokova A, Jess T, Elmahdi R |
Journal of virology | 2024 |
|
Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data
Hay JA, Routledge I, Takahashi S |
Epidemics | 2024 |
|
Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2.
Huang X, Liang C, Li M, Chen H, Li Z, Ruan Q, Hu X, Zeng L, Lin H, Zhao W, Xiao J, Sun L, Sun J |
Human vaccines | 2023 |
|
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
Karaba AH, Johnston TS, Beck E, Laeyendecker O, Cox AL, Klein SL, Sullivan DJ |
mBio | 2023 |
|
Lung Expression of Macrophage Markers CD68 and CD163, Angiotensin Converting Enzyme 2 (ACE2), and Caspase-3 in COVID-19.
Ziablitsev DS, Kozyk M, Strubchevska K, Dyadyk OO, Ziablitsev SV |
2023 | |
|
SARS-CoV-2 spike S2-specific neutralizing antibodies
Li CJ, Chang SC |
Emerging Microbes & Infections | 2023 |
|
Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping and sequence analysis
N\u2019Guessan A, Kailasam S, Mostefai F, Poujol R, Grenier JC, Ismailova N, Contini P, De Palma R, Haber C, Stadler V, Bourque G, Hussin JG, Shapiro BJ, Fritz JH, Piccirillo CA |
iScience | 2023 |
|
Detection of Antibodies against Endemic and SARS-CoV-2 Coronaviruses with Short Peptide Epitopes
Szardenings M, Delaroque N, Kern K, Ramirez-Caballero L, Puder M, Ehrentreich-Förster E, Beige J, Zürner S, Popp G, Wolf J, Borte S |
Human vaccines | 2023 |
|
Massively-multiplexed epitope mapping techniques for viral antigen discovery
Hu D, Irving AT |
Frontiers in immunology | 2023 |
|
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Wu J, Yang H, Yu D, Yang X |
2023 | |
|
High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines
Joseph JO, Ylade M, Daag JV, Aogo R, Crisostomo MV, Mpingabo P, Premkumar L, Deen J, Katzelnick L |
Research square | 2023 |
|
Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection
Lauritsen CJ, Trinh IV, Desai SP, Clancey E, Murrell AE, Rambaran S, Chandra S, Elliott DH, Smira AR, Mo Z, Stone AE, Agbodji A, Dugas CM, Satou R, Pridjian G, Longo S, Ley SH, Robinson JE, Norton EB, Piedimonte G, Gunn BM |
2023 | |
|
Pharmacokinetics of High-titer Anti-SARS-CoV-2 Human Convalescent Plasma in High-risk Children
Oren Gordon, Mary K. Brosnan, Steve Yoon, Dawoon Jung, Kirsten Littlefield, Abhinaya Ganesan, Christopher A. Caputo, Maggie Li, William Morgenlander, Stephanie N. Henson, Alvaro A. Ordonez, Patricia De Jesus, Elizabeth W. Tucker, Nadine Peart Akindele, Zexu Ma, Jo Wilson, Camilo A. Ruiz-Bedoya, M. Elizabeth M. Younger, Evan M Bloch, Shmuel Shoham, David Sullivan, Aaron A.R. Tobian, Kenneth R. Cooke, Ben Larman, Jogarao Gobburu, Arturo Casadevall, Andrew Pekosz, Howard M Lederman, Sabra Klein, Sanjay K. Jain |
JCI Insight | 2022 |
|
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
H Natarajan, S Xu, A Crowley, S Butler, J Weiner, E Bloch, K Littlefield, S Benner, R Shrestha, O Ajayi, W Wieland-Alter, D Sullivan, S Shoham, T Quinn, A Casadevall, A Pekosz, A Redd, A Tobian, R Connor, P Wright, M Ackerman |
BMC Immunology | 2022 |
|
An Immunoproteomic Survey of the Antibody Landscape: Insights and Opportunities Revealed by Serological Repertoire Profiling
S Ionov, J Lee |
Frontiers in immunology | 2022 |
|
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
A Crowley, H Natarajan, A Hederman, C Bobak, J Weiner, W Wieland-Alter, J Lee, E Bloch, A Tobian, A Redd, J Blankson, D Wolf, T Goetghebuer, A Marchant, R Connor, P Wright, M Ackerman |
eLife | 2022 |
|
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
D Gregory, A Vannier, A Duey, T Roady, R Dzeng, M Pavlovic, M Chapin, S Mukherjee, H Wilmot, N Chronos, R Charles, E Ryan, R LaRocque, T Miller, W Garcia-Beltran, J Thierauf, A Iafrate, S Mullenbrock, M Stump, R Wetzel, R Polakiewicz, V Naranbhai, M Poznansky |
Virulence | 2022 |
|
Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
G Nasrallah |
EBioMedicine | 2022 |
|
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide
N Vanderheijden, A Stevaert, J Xie, X Ren, C Barbezange, S Noppen, I Desombere, B Verhasselt, P Geldhof, N Vereecke, V Stroobants, D Oh, M Vanhee, L Naesens, H Nauwynck |
Frontiers in immunology | 2022 |
|
Deconvoluting virome-wide antibody epitope reactivity profiles
DR Monaco, SV Kottapalli, FP Breitwieser, DE Anderson, L Wijaya, K Tan, WN Chia, K Kammers, P Caturegli, K Waugh, M Roederer, M Petri, DW Goldman, M Rewers, LF Wang, HB Larman |
EBioMedicine | 2022 |
|
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review
D Focosi, M Franchini, M Tuccori, M Cruciani |
Human vaccines | 2022 |
|
Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait
T Venkataraman, C Valencia, M Mangino, W Morgenlander, S Clipman, T Liechti, A Valencia, P Christofidou, T Spector, M Roederer, P Duggal, H Larman |
Immunity | 2022 |
|
A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs
D Pattinson, P Jester, L Guan, S Yamayoshi, S Chiba, R Presler, H Rao, K Iwatsuki-Horimoto, N Ikeda, M Hagihara, T Uchida, K Mitamura, P Halfmann, G Neumann, Y Kawaoka |
Viruses | 2022 |
|
Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology
Tiu CK, Zhu F, Wang LF, de Alwis R |
Pathogens | 2022 |
|
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses.
Angkeow JW, Monaco DR, Chen A, Venkataraman T, Jayaraman S, Valencia C, Sie BM, Liechti T, Farhadi PN, Funez-dePagnier G, Sherman-Baust CA, Wong MQ, Ruczinski I, Caturegli P, Sears CL, Simner PJ, Round JL, Duggal P, Laserson U, Steiner TS, Sen R, Lloyd TE, Roederer M, Mammen AL, Longman RS, Rider LG, Larman HB |
Immunity | 2022 |
|
Broadly neutralizing antibodies target the coronavirus fusion peptide
Dacon C, Tucker C, Peng L, Lee CC, Lin TH, Yuan M, Cong Y, Wang L, Purser L, Williams JK, Pyo CW, Kosik I, Hu Z, Zhao M, Mohan D, Cooper AJ, Peterson M, Skinner J, Dixit S, Kollins E, Huzella L, Perry D, Byrum R, Lembirik S, Drawbaugh D, Eaton B, Zhang Y, Yang ES, Chen M, Leung K, Weinberg RS, Pegu A, Geraghty DE, Davidson E, Douagi I, Moir S, Yewdell JW, Schmaljohn C, Crompton PD, Holbrook MR, Nemazee D, Mascola JR, Wilson IA, Tan J |
Science (New York, N.Y.) | 2022 |
|
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP II, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K |
mSphere | 2022 |
|
Detecting antibody reactivities in Phage ImmunoPrecipitation Sequencing data
Chen A, Kammers K, Larman HB, Scharpf RB, Ruczinski I |
BMC Genomics | 2022 |
|
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
Asamoah-Boaheng M, Grunau B, Karim ME, Jassem AN, Bolster J, Marquez AC, Scheuermeyer FX, Goldfarb DM |
Frontiers in immunology | 2022 |
|
Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19.
Kombarova SY, Aleshkin AV, Novikova LI, Bochkareva SS, Zatevalov AM, Mekhtiev ER, Mizaeva TE, Basov AA, Borisova OY, Likhanskaya EI, Voropaeva EA, Urban YN, Mitrokhin SD, Shkoda AS, Gushchin VA, Sinyavin AE, Nikiforova MA, Lebedin YS, Karaulov AV |
Bulletin of Experimental Biology and Medicine | 2022 |
|
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Herman JD, Wang C, Burke JS, Zur Y, Compere H, Kang J, Macvicar R, Taylor S, Shin S, Frank I, Siegel D, Tebas P, Choi GH, Shaw PA, Yoon H, Pirofski LA, Julg BD, Bar KJ, Lauffenburger D, Alter G |
Cell reports. Medicine | 2022 |
|
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, Ogbe A |
Nature reviews. Immunology | 2022 |
|
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.
Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP 2nd, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K |
medRxiv : the preprint server for health sciences | 2022 |
|
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
Bezawit Woldemeskel, Caroline Garliss, Joel N. Blankson |
Journal of Clinical Investigation | 2021 |
|
Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline Garliss, Laurene S Cheung, Dilshad Choudhury, Jiajia Zhang, Luis Aparicio, Sadhana Bom, Rufiaat Rashid, Justina X. Caushi, Emily Han-Chung Hsiue, Katherine Cascino, Elizabeth A Thompson, Abena K. Kwaa, Dipika Singh, Sampriti Thapa, Alvaro A. Ordonez, Andrew Pekosz, Franco D'Alessio, Jonathan D. Powell, Srinivasan Yegnasubramanian, Shibin Zhou, Drew Pardoll, Hongkai Ji, Andrea Cox, Joel N Blankson, Kellie N Smith |
Journal of Clinical Investigation | 2021 |
|
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, RA Booth, Y Durocher, M Cuperlovic-Culf, SA Bennett, AM Crawley, PM Giguère, C Cooper, MA Langlois |
EBioMedicine | 2021 |
|
Effect of time and titer in convalescent plasma therapy for COVID-19
P de Candia, F Prattichizzo, S Garavelli, RL Grotta, AD Rosa, A Pontarelli, R Parrella, A Ceriello, G Matarese |
iScience | 2021 |
|
Passive Immunity Should and Will Work for COVID-19 for Some Patients:
N Cimolai |
2021 | |
|
Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals
D Stelitano, SP Weisberg, MP Goldklang, Y Zhu, FT Bovier, GF Kalantarov, G Greco, D Decimo, G Franci, M Cennamo, G Portella, M Galdiero, C Mathieu, B Horvat, IN Trakht, A Moscona, MA Whitt, M Porotto, R Dutch |
mSphere | 2021 |
|
Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin
D Focosi, A Genoni, E Lucenteforte, S Tillati, A Tamborini, PG Spezia, L Azzi, A Baj, F Maggi |
Life Sciences | 2021 |
|
Multicomponent vaccines to fight SARS-CoV-2 variants of concern
A Cassone, R Cauda |
Vaccine | 2021 |
|
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
KW Ng, N Faulkner, AG Wrobel, SJ Gamblin, G Kassiotis |
Seminars in Immunology | 2021 |
|
Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?
P Finotti |
Cell Stress and Chaperones | 2021 |
|
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
D Focosi, M Franchini, L Pirofski, T Burnouf, DL Fairweather, MJ Joyner, A Casadevall |
Viruses | 2021 |
|
Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development
A Mallano, A Ascione, M Flego |
International Reviews of Immunology | 2021 |
|
SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients
MS Makatsa, MB Tincho, JM Wendoh, SD Ismail, R Nesamari, F Pera, S de Beer, A David, S Jugwanth, MP Gededzha, N Mampeule, I Sanne, W Stevens, L Scott, J Blackburn, ES Mayne, RS Keeton, WA Burgers |
Frontiers in Plant Science | 2021 |
|
Why are there so few (or so many) circulating coronaviruses?
BL Rice, DC Douek, AB McDermott, BT Grenfell, CJ Metcalf |
Trends in Immunology | 2021 |
|
COVID-19 convalescent plasma
Tobian AA, Cohn CS, Shaz BH |
Blood | 2021 |
|
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Loyal L, Braun J, Henze L, Kruse B, Dingeldey M, Reimer U, Kern F, Schwarz T, Mangold M, Unger C, Dörfler F, Kadler S, Rosowski J, Gürcan K, Uyar-Aydin Z, Frentsch M, Kurth F, Schnatbaum K, Eckey M, Hippenstiel S, Hocke A, Müller MA, Sawitzki B, Miltenyi S, Paul F, Mall MA, Wenschuh H, Voigt S, Drosten C, Lauster R, Lachman N, Sander LE, Corman VM, Röhmel J, Meyer-Arndt L, Thiel A, Giesecke-Thiel C |
Science (New York, N.Y.) | 2021 |
|
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2.
Natarajan H, Xu S, Crowley AR, Butler SE, Weiner JA, Bloch EM, Littlefield K, Benner SE, Shrestha R, Ajayi O, Wieland-Alter W, Sullivan D, Shoham S, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Connor RI, Wright PF, Ackerman ME |
medRxiv : the preprint server for health sciences | 2021 |
|
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike.
Crowley AR, Natarajan H, Hederman AP, Bobak CA, Weiner JA, Wieland-Alter W, Lee J, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Wolf D, Goetghebuer T, Marchant A, Connor RI, Wright PF, Ackerman ME |
medRxiv : the preprint server for health sciences | 2021 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)